Evidence map›Paper›PMID 39973571›Full record

ArticleANZ journal of surgery2025

Pancreatic resection for metachronous colorectal cancer metastases: a case series multicenter study.

Francesco Palmieri, Francesco Lancellotti, Francesco Ferrara, Thomas Satyadas, Davide Gobatti, Luis Felipe Abreu de Carvalho, Filip Gryspeerdt, Grazia Conte, Federico Mocchegiani, Roberto Sampietro and 1 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in ANZ journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesco PalmieriUniversità Vita-Salute San Raffaele, Colorectal Surgery Unit, IRCCS Ospedale San raffaele, Milano, Italy.ORCID 0000-0002-8067-2936
Francesco LancellottiHepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, Manchester, M139WL, UK.
Francesco FerraraDepartment of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Unit of General and Oncological Surgery, "Paolo Giaccone" University Hospital, Palermo, Italy.ORCID 0000-0002-8208-1945
Thomas SatyadasHepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, Manchester, M139WL, UK.
Davide GobattiChirurgia Generale Oncologica d'Urgenza, Ospedale Moriggia Pelascini, Gravedona ed Uniti, Italy.
Luis Felipe Abreu de CarvalhoDepartment of General, HPB and Liver Transplantation, Ghent University Hospital, Gravedona ed Uniti, Belgium.
Filip GryspeerdtDepartment of General, HPB and Liver Transplantation, Ghent University Hospital, Gravedona ed Uniti, Belgium.
Grazia ConteClinica Di Chirurgia Epatobiliare Pancreatica e dei Trapianti, Ospedali Riuniti Delle Marche, Ancona, Italy.
Federico MocchegianiClinica Di Chirurgia Epatobiliare Pancreatica e dei Trapianti, Ospedali Riuniti Delle Marche, Ancona, Italy.
Roberto SampietroChirurgia Generale Oncologica d'Urgenza, Ospedale Moriggia Pelascini, Gravedona ed Uniti, Italy.
Pierpaolo SileriUniversità Vita-Salute San Raffaele, Colorectal Surgery Unit, IRCCS Ospedale San raffaele, Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreas resection for metachronous colorectal cancer metastasis is episodic and the role of surgery in the management of these patients is still debated.

methodsWe recruited seven patients from three different centres and analyzed 30-day morbidity and mortality, oncological outcomes at 6 and 12 months.

resultsThere was no postoperative mortality. Complications occurred in two patients (28,6%). All patients completed at least a 12-months follow-up. At 6-month follow-up, only one patient had a recurrence. At 12-month follow-up, no patients died for disease recurrence and one more patient had a new recurrence.

conclusionOur series supports the feasibility and safety of pancreas resection in metastatic colorectal cancer suggesting that radical resection may improve the patient's prognosis.

Indexed as

Colorectal NeoplasmsNeoplasms, Second PrimaryPancreatectomyPancreatic NeoplasmsAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedTreatment Outcomecolorectal carcinomacolorectal metastasespancreaspancreas metastasespancreas resection

Identifiers

PMID39973571
PMCPMC12227840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.